PRO-DEX, INC. Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent
PRO-DEX, INC. (PDEX) reported Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent of $23.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent · last filed 2021-09-09
- PRO-DEX, INC. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2021 was $23.00K.
- PRO-DEX, INC. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2020 was -$23.00K.
- PRO-DEX, INC. other comprehensive income (loss), available-for-sale securities, tax, portion attributable to parent for fiscal 2019 was $0.00.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent 12 month |
|---|---|
| 2021-06-30 | $23.00K 10-K · filed 2021-09-09 |
| 2020-06-30 | -$23.00K 10-K · filed 2021-09-09 |
| 2019-06-30 | $0.00 10-K · filed 2020-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |